SCHEMBL13430256

SCHEMBL13430256

O=C(NC1=NCC(CCNc2ncnc3oc(-c4ccccc4)nc23)S1)Nc1cccc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 5/20 0.43
▸ AURKA O14965 13/20 0.40
▸ AURKB Q96GD4 11/20 0.40
▸ CDK8 P49336 2/20 0.39
▸ PLK4 O00444 1/20 0.39
▸ ACOX3 O15254 1/20 0.39
▸ MAPK13 O15264 1/20 0.39
▸ DYRK3 O43781 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ CHEK2 O96017 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ RET P07949 1/20 0.39
▸ MET P08581 1/20 0.39
▸ ROS1 P08922 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ KIT P10721 1/20 0.39
▸ RPS6KB1 P23443 1/20 0.39
▸ EPHA2 P29317 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ FRK P42685 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13429733 0.92 ADK (0.48) ADKAURKAAURKB
SCHEMBL13430258 0.91 ADK (0.43) ADKAURKAAURKBRPS6KB1
SCHEMBL13429734 0.82 AURKA (0.53) ADKAURKAAURKBNTRK3NTRK2
SCHEMBL13399980 0.79 AURKA (0.63) ADKAURKAAURKBCDK8PLK4
SCHEMBL13625779 0.79 AURKA (0.65) AURKAAURKB
SCHEMBL13689923 0.78 AURKA (0.61) AURKAAURKBCDK8PLK4ACOX3
SCHEMBL13625873 0.76 AURKA (0.65) AURKAAURKB
SCHEMBL13430270 0.76 KDR (0.40) AURKAAURKBRPS6KB1KDR
SCHEMBL13430289 0.75 EGFR (0.56) AURKAPDGFRBKITKDR
SCHEMBL13625527 0.74 AURKA (0.45) AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765953-B2 Compounds and methods for the treatment of pain and other diseases AQUILUS PHARMACEUTICALS, INC. (US) 2014-07-01 — — US disclosed
WO-2010036629-A2 FUSED MULTICYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2010-04-01 — — WO disclosed
Send feedback